Xarelto Lawsuit Claims Continue To Grow

Xarelto-Lawsuit-Info-Xarelto-Lawsuit-Attorneys-Xarelto-lawsuit-Settlements-Funeral-Death-Blood-Thinner-Lawsuit-2


Xarelto lawsuits in 2017 are expected to grow and reach record highs. Pharmaceutical company Johnson & Johnson is already facing nearly 20,000 lawsuits, that number could still increase over the next twelve months. “It’s staggering,” says the site representative. “The number of people who have been affected by this medication is absolutely mind blowing and there are more and more cases coming forward every day.”

Xarelto is an anticoagulant that was marketed to replace the popular medication warfarin when it was determined that warfarin had been causing internal bleeding in some patients. The FDA approved the use of Xarelto for this purpose in 2011 for patients who had undergone knee and hip replacement surgeries. The medication was supposed to prevent deep vein thrombosis and pulmonary embolism in these patients.

Manufacturers of the medication, Janssen Pharmaceutical, a division of Johnson & Johnson, and Bayer Healthcare have now expanded the use of the medication to include those who are at risk for heart attacks. The manufacturers claim that clinical trials have shown significant promise for patients who have suffered or are at risk for developing blood clots in the heart.

“The problem here,” says the representative for xarelto-lawsuits.org, “is that they are actively making this drug available and actively marketing it while there are literally tens of thousands of people who have been seriously affected by it.”

Claims against the pharmaceutical companies state that the drug causes severe internal bleeding for which there is no remedy to stop the bleeding. Xarelto reduces the ability of the blood to clot, which is why it was approved by the FDA for use against blood clots. This is also why it can increase the risk of bleeding, which could be excessive bleeding and therefore life-threatening.

While the medication is pending approval from the FDA for use in heart patients, there are thousands of cases going to trial against Janssen Pharmaceutical and Johnson & Johnson seeking damages for side effects, some of which have been fatal.